Amgen's Q4 2024 earnings show a 19% revenue increase year-on-year, with non-GAAP EPS up 13% in Q4 and 6% for the full year.

Cantor Fitzgerald adjusted its outlook on Amgen shares (NASDAQ:AMGN), reducing the price target from the previous $405.00 to $340.00. Despite the lowered price target, the firm maintained its ...

Shares of Amgen (Nasdaq: AMGN) started crashing in early November and didn’t improve when the company released data from a phase 2 clinical trial for its weight-loss candidate MariTide.

Its pipeline progress, especially its obesity drug MariTide, positions Amgen, Inc. (NASDAQ:AMGN) for long-term growth. The company’s move towards rare diseases exhibited strong momentum in late ...

Shares of Amgen started crashing in early November and didn’t improve when the company released data from a Phase 2 clinical trial for its weight-loss candidate MariTide. That plunge has set the ...

Its pipeline progress, especially its obesity drug MariTide, positions Amgen Inc. (NASDAQ:AMGN) for long-term growth. The company’s move towards rare diseases exhibited strong momentum in late ...

We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds.In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against other best ...

Healthcare has become the second-best performer in the S&P 500 (SP500) this month, prompting market observers to foresee a brighter 2025 for a sector that has struggled to outperform the broader ...

We recently compiled a list of the 7 Cheap Quarterly Dividend Stocks to Invest in. In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against the other cheap ...

We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against other best ...

We recently compiled a list of the 7 Cheap Quarterly Dividend Stocks to Invest in. In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against the other cheap ...